OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 14 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $451,000 | -8.9% | 1,649,000 | 0.0% | 0.02% | -11.1% |
| Q2 2016 | $495,000 | -23.4% | 1,649,000 | -0.5% | 0.02% | -14.3% |
| Q1 2016 | $646,000 | -37.3% | 1,658,000 | -4.9% | 0.02% | -36.4% |
| Q4 2015 | $1,030,000 | -14.2% | 1,743,000 | +0.2% | 0.03% | -5.7% |
| Q3 2015 | $1,201,000 | -52.5% | 1,739,000 | -35.7% | 0.04% | -45.3% |
| Q2 2015 | $2,530,000 | -1.2% | 2,706,000 | +21.2% | 0.06% | 0.0% |
| Q1 2015 | $2,562,000 | -5.5% | 2,233,000 | -17.3% | 0.06% | -3.0% |
| Q4 2014 | $2,712,000 | – | 2,699,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $3,550,000 | 0.43% |
| Telemetry Investments, L.L.C. | 2,500,000 | $875,000 | 0.33% |
| UBS OCONNOR LLC | 7,500,000 | $2,780,000,000 | 0.05% |